Recalling firm
Imprimis NJOF, LLC
Product type
Drug
Status
Ongoing
Report date
2026-01-14
Distribution
U.S Nationwide
Firm state
NJ
Product quantity
314 boxes of 6,280 pre-filled syringes
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental MonitoringReason for recall
Presence of particulate matter - Glass like particles.
Product description
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Code / lot info
Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.
Other recalls SPEQ maps to Environmental Monitoring
See all Environmental Monitoring recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.